Aslan Pharmaceuticals Pte Ltd:企業のM&A・事業提携・投資動向

◆英語タイトル:Aslan Pharmaceuticals Pte Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C2020
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:65
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:シンガポール
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Aslan Pharmaceuticals Pte Ltd – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Aslan Pharmaceuticals Pte Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Aslan Pharmaceuticals Pte Ltd since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Aslan Pharmaceuticals Pte Ltd’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Aslan Pharmaceuticals Pte Ltd. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Aslan Pharmaceuticals Pte Ltd’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Aslan Pharmaceuticals Pte Ltd and its subsidiaries since 2007.
- Information about key financial and legal advisors for Aslan Pharmaceuticals Pte Ltd’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Aslan Pharmaceuticals Pte Ltd’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
PARTNERSHIP 8
Partnership – Overview 8
Partnership – Deal reports 9
CAPITAL RAISING 34
Capital Raising – Overview 34
Capital Raising – Deal reports 35
PRIVATE EQUITY & OWNERSHIP 51
Private Equity and Ownership – Overview 51
Private Equity and Ownership – Deal reports 52
APPENDIX 55
Contact Us 55
About MarketLine Financial Deals Database 55
Deal Definition and Methodology 57
About MarketLine 64

List of Tables
Table 1: Aslan Pharmaceuticals Pte Ltd partnership volume and value trend (2014-YTD2018)
Table 2: Aslan Pharmaceuticals Pte Ltd partnership trend by key deal type (2014-YTD2018)
Table 3: Aslan Pharmaceuticals Pte Ltd capital raising volume and value trend (2014-YTD2018)
Table 4: Aslan Pharmaceuticals Pte Ltd capital raising by deal type (2014-YTD2018)
Table 5: Aslan Pharmaceuticals Pte Ltd private equity and ownership volume and value trend (2014-YTD2018)
Table 6: Aslan Pharmaceuticals Pte Ltd private equity and ownership activity by deal type (2014-YTD2018)

List of Figures
Figure 1: Aslan Pharmaceuticals Pte Ltd partnership volume and value trend (2014-YTD2018)
Figure 2: Aslan Pharmaceuticals Pte Ltd partnership trend by key deal type (2014-YTD2018)
Figure 3: Aslan Pharmaceuticals Pte Ltd capital raising volume and value trend (2014-YTD2018)
Figure 4: Aslan Pharmaceuticals Pte Ltd capital raising by deal type (2014-YTD2018)
Figure 5: Aslan Pharmaceuticals Pte Ltd private equity and ownership volume and value trend (2014-YTD2018)
Figure 6: Aslan Pharmaceuticals Pte Ltd private equity and ownership by deal type (2014-YTD2018)

★海外企業調査レポート[Aslan Pharmaceuticals Pte Ltd:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Taishin International Bank Co Ltd:企業の戦略・SWOT・財務分析
    Taishin International Bank Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Taishin International Bank Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Ace Hardware Corporation:企業の戦略的SWOT分析
    Ace Hardware Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Emera Inc (EMA):電力:M&Aディール及び事業提携情報
    Summary Emera Inc (Emera) is an energy and services company. It invests in electricity, natural gas and utility energy services. Through ownership and equity investments in various companies, Emera generates, transmits and distributes electricity; procures, transmits and distributes natural gas; mar …
  • Cairn India Ltd (CAIRN)-石油・ガス分野:企業M&A・提携分析
    Summary Cairn India Limited (Cairn India) is an independent oil and gas company. It explores for, develops, and produces oil and natural gas. The company has varying working interests in India, Sri Lanka and South Africa. Its blocks are located in the basins of Barmer, Krishna- Godavari, the Palar-P …
  • Hibu Group Limited:戦略・SWOT・企業財務分析
    Hibu Group Limited - Strategy, SWOT and Corporate Finance Report Summary Hibu Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Kootenai Electric Cooperative, Inc.:企業の戦略的SWOT分析
    Kootenai Electric Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Targa Resources Partners LP (NGLS PR A):石油・ガス:M&Aディール及び事業提携情報
    Summary Targa Resources Partners LP (Targa Resources) is an independent midstream company. It carries out the gathering, compressing, treating, processing and sale of natural gas, and storing, fractionating, treating, transporting and selling natural gas liquids (NGLs) and NGL products. The company …
  • Actinogen Medical Ltd (ACW)-製薬・医療分野:企業M&A・提携分析
    Summary Actinogen Medical Ltd (Actinogen), formerly Actinogen Ltd is a biotechnology company that undertakes research in Alzheimer’s disease and other chronic neurodegenerative diseases. The company’s xanamem is a novel drug under development for the treatment of Alzheimer's disease. It develops dru …
  • I.Ceram SA (ALICR):医療機器:M&Aディール及び事業提携情報
    Summary I.Ceram SA (I.Ceram) is a medical equipment and device company that designs, manufactures, and markets joint implants for neurosurgery and other surgical procedures. The company’s products include bone fillers, alumina bio-ceramic implants, trepan caps, cervical plates and blocks for cervica …
  • Galecto Biotech AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Galecto Biotech AB (Galecto Biotech) is a drug development company that focuses on the development of galectin modulators for the treatment of cancer, fibrosis and inflammation. The company develops activators and inhibitors of galectins. Its pipeline products include TD139 inhaled Gal -3 in …
  • Dometic Group AB:企業の戦略・SWOT・財務情報
    Dometic Group AB - Strategy, SWOT and Corporate Finance Report Summary Dometic Group AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Petrobras Argentina SA:石油・ガス:M&Aディール及び事業提携情報
    Summary Petrobras Argentina SA (PESA), a subsidiary of Pampa Energia S.A, is an integrated energy company. It carries out the exploration and production of crude oil and natural gas, refining of crude oil, transportation, and marketing of oil and refined products. The company’s product portfolio inc …
  • Hooper Holmes Inc (HH)-製薬・医療分野:企業M&A・提携分析
    Summary Hooper Holmes Inc (Hooper Holmes) is a provider of health and screening services. The company provides health services such as individual screenings at home or work, onsite screenings for small and large companies, remote screenings for individuals and eligible family members, convenient wal …
  • Atrion Corp (ATRI):企業の財務・戦略的SWOT分析
    Atrion Corp (ATRI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Pinnacle West Capital Corporation:企業の戦略・SWOT・財務分析
    Pinnacle West Capital Corporation - Strategy, SWOT and Corporate Finance Report Summary Pinnacle West Capital Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Extraction Oil & Gas Inc (XOG):企業の財務・戦略的SWOT分析
    Extraction Oil & Gas Inc (XOG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • ABB Ltd (ABBN)-エネルギー分野:企業M&A・提携分析
    Summary ABB Ltd. (ABB) is a provider of power and automation technologies. The company provides solutions for secure, energy-efficient generation, transmission and distribution of electricity and for increasing productivity in industrial, commercial and utility operations. ABB’s product and service …
  • The Charles Schwab Corporation:戦略・SWOT・企業財務分析
    The Charles Schwab Corporation - Strategy, SWOT and Corporate Finance Report Summary The Charles Schwab Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • QPS Austria GmbH-製薬・医療分野:企業M&A・提携分析
    Summary QPS Austria GmbH (QPS), a subsidiary of QPS Holdings LLC, is a contract research organization that performs preclinical and clinical research. The company offers in vivo services which involves generating, characterizing and maintaining transgenic disease models and use them for drug testing …
  • Intershop Communications AG (ISH2):企業の財務・戦略的SWOT分析
    Summary Intershop Communications AG (Intershop), formerly NetConsult GmbH, is an information technology company that develops and offers integrated e-commerce solutions. The company provides services such as omni-channel management, experience management, product information management, marketing an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆